Does anyone know if GSK drug CAB-ULA is the same
Post# of 157741
(Total Views: 594)
Posted On: 02/06/2025 8:30:37 PM
Does anyone know if GSK drug CAB-ULA is the same as HIV (ULA Q4/Q6M)? It doesn’t appear to be, but I’m just thinking Q4/Q6M ultra long-acting is cabotegravir. I don’t see anything specificity stating that but I just started looking based on GSK newest PR and I don’t see HIV (ULA Q4/Q6M) really mentioned before today.
“5 major new product approvals expected in 2025 including: Blenrep (multiple myeloma) and depemokimab (severe asthma and CRSwNP(1)); plus phase III readouts: camlipixant (refractory chronic cough) and tebipenem (complicated UTI); and important pipeline catalysts: Respiratory (depemokimab COPD); Oncology (B7-H3 & B7-H4 ADCs); HIV (ULA Q4/Q6M)”
https://www.gsk.com/en-gb/media/press-release...-outlook/3
Looking at their pipeline now.
https://www.gsk.com/media/11766/4q2024-pipeline-list.xlsx
https://www.sec.gov/Archives/edgar/data/11313...5-0225.htm
Alright, looks like this is the first time it’s been mentioned. I searched a bunch of spots and this 6k was the latest filing and it mentioned their new long-acting HIV drug which appears to be unknown drug at the time of my writing.
“5 major new product approvals expected in 2025 including: Blenrep (multiple myeloma) and depemokimab (severe asthma and CRSwNP(1)); plus phase III readouts: camlipixant (refractory chronic cough) and tebipenem (complicated UTI); and important pipeline catalysts: Respiratory (depemokimab COPD); Oncology (B7-H3 & B7-H4 ADCs); HIV (ULA Q4/Q6M)”
https://www.gsk.com/en-gb/media/press-release...-outlook/3
Looking at their pipeline now.
https://www.gsk.com/media/11766/4q2024-pipeline-list.xlsx
https://www.sec.gov/Archives/edgar/data/11313...5-0225.htm
Alright, looks like this is the first time it’s been mentioned. I searched a bunch of spots and this 6k was the latest filing and it mentioned their new long-acting HIV drug which appears to be unknown drug at the time of my writing.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
— Jeremiah 51:36